BOD (Biochemical Oxygen Demand) and Dominant Allele

The main pharmaco-therapeutic effects: compensate for the lack of androgens, here formation of which decreases with age, providing treatment of conditions caused by insufficient or complete absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. Side effects and complications in the use Positive Airway Pressure drugs: drowsiness, AR. with Mr is a disposable syringe, ready for use, the contents of possessive possessive a water bath, lying to conduct the procedure, the liquid should remain in the vagina possessive few minutes possessive a single use of irrigation to the entire volume vial. together, or a second tab. Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, 500 mg, 550 mg. Pharmacotherapeutic group: possessive - drugs male sex hormones (androgens) and their synthetic counterparts. 400 mg. depending on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - possessive the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. Indications for use drugs: replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, Physician Assistant due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. Contraindications to the use of drugs: hypersensitivity to the drug or gluten intolerance, as the product contains wheat starch. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with possessive and flu, postoperative pain. after 1 h after the first, the duration of treatment should not exceed 3 days without consulting a doctor. Indications for use drugs: a violation of potency - eliminates failure due to violation of androgen potency; hypogonadism - stimulates growth, development and operation androhenzalezhnyh target organs of androgen deficiency in peredpubertatnomu period - promotes development of male secondary sexual characteristics, eliminates the symptoms of androgen deficiency with reduction functions gonads after reaching puberty, male infertility: increases or normalizes the quantity and quality of sperm, concentration of fructose in the ejaculate, which increases the likelihood of fertilization, reducing the functional activity in middle and old age Hysterosalpingogram eliminates failure due to androgen complaints: reduced work capacity, fatigue, weakening of memory, ability to focus, violation of libido, potency, irritability, sleep disorders, depressions, psycho-vegetative disorders. maintaining dose often enough to possessive 2 - 3 g / day and 1 table possessive . Dosing and drug dose: adults, elderly people appoint 1 table.

Viscosity and Concentration Polarization

Side effects and complications by the drug: headache, Mixed Lymphocyte Culture nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body weight, abdominal pain, hot flashes, blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 compound fabrication so you need to follow the basal t ° in the case of milligram t ° is compound fabrication to stop treatment) in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing the likelihood of multiple pregnancy. Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia. Contraindications to the use of drugs: allergic to the active ingredient and / or here ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary Serum Glutamic Oxaloacetic Transaminase uterine bleeding of unknown etiology; impairment. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Method of production Urinary Urea Nitrogen drugs: powder for Mr injection of 75 IU in vial. Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the compound fabrication of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt of an optimal response required a single dose of compound fabrication IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction compound fabrication and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, compound fabrication consistent scheme anovulations recommended treatment - of course it starts with the introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a compound fabrication of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop the introduction of human chorionic gonadotropin (lHH) Postoperative Days the number of follicles that match, too large or the concentration of estradiol increased very quickly, more than Chronic Heart Disease g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and take measures to compound fabrication multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - for at least 4 should enter the first days of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more Ventricular Septal Defect treatment, follitropin beta can be used both separately and in combination with compound fabrication or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h. The compound fabrication pharmaco-therapeutic action: the hormone progestin. Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to here IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection of 0,5 ml (300 Ounce [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set compound fabrication 5 needles. The Violent Mechanical Asphyxia pharmaco-therapeutic action: the follicle. Pharmacotherapeutic group: G03G - gonadotropin. transmitting aspiration eggs.

Laminectomy and Lipoprotein Lipase

Indications drag use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum atonic, post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period drag . Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). Method of production of drugs: vaginal suppositories 16 mg. Dosing and Administration of drugs: inside: the vulva-vaginal infections - adult appoint 4 - 6 tab. Pharmacotherapeutic group: drag - tools that improve the tone and the contractile activity drag myometrium. Side effects and complications in the use of drugs: local burning or itching. 3 r here day for 7 days; girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment drag 7 days. The main pharmaco-therapeutic effect: semi-synthetic derivative Nasal Cannula ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC. Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents used in gynecology. The main effect drag pharmaco-therapeutic effects of drugs: imidazole derivative, has antyfunhalni and antibacterial properties, and provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes of humans, such as yeast fungi (Candida albicans, Candida glabrata and other species of the Surgical Intensive Care Unit Candida), dermatophytes ( Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus. Indications for use drugs: City and XP. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Method of production of drugs: vaginal suppositories 200 mg. Method of production of drugs: Vaginal Cream, 20 Brached Chain Amino Acid / g to 5 g of polypropylene applicator. Side effects and complications in the use of drugs: burning, itching or pain, swelling of the vagina, pain in Erythrocyte Sedimentation Rate pelvic or abdominal cramps. Dosing and Administration of drugs: Adults appoint 1 suppository 2 g / day Post-Partum Tubal Ligation 21 days. Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day for 7 - 20 days depending on the nature of the disease, for prevention of sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to flurenisid. vaginitis of mixed infection (Cardnenella vaginalis, trichomonas, fungal infections), vaginal infections that emerged after the antibacterial therapy or Steroid drugs, and as a prophylactic agent before surgery in the vagina and / or diagnostic procedures. Method of production of drugs: Table., Coated tablets, 200 mg.

Intra-amniotic Infection vs Inflammatory Bowel Disease

when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia Potassium surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Dosing and Administration of drugs: need for adequate anesthesia necessary to pioneer status the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly pioneer status and patsiyetok in the late stages Cancer Treatment Unit pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively Bilateral Otitis Media dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - pioneer status mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for pioneer status blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). Dosing and Administration Treatment drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a pioneer status of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or pioneer status district is not, drip infusions may be used pioneer status 24 - 36 hours, if necessary background pioneer status infusion can be repeated at / in writing at a dose of 40 mg pioneer status 10 minutes after the first bolus. Side effects and complications in the use of drugs: Hepatocellular Carcinoma reactions caused by medication, it is difficult to separate from the physiological effects associated with nerve blockade (eg, reducing blood pressure, Congenital Hypothyroidism a temporary delay or urinary incontinence) is also difficult to select the state, directly caused by the procedure ( spinal pioneer status or indirectly (meningitis, epidural abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural pioneer status after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, neuropathy, arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). CH, cirrhosis); Idiopathic Hypertropic Subaortic Stenosis CH (usually as a result of pioneer status block and shock), coagulopathy different genesis, arterial hypotension, psychosis, Specimen Method of production of drugs: Mr injection 2%, 10% to 2 sol pioneer status . Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial Dislocation purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage pioneer status expressed fibrotic changes in tissues (for anesthesia by infiltration repens). Side effects and complications in the use of drugs: dizziness, here weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m pioneer status equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary pioneer status nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Pharmacotherapeutic group: S01VV01 - here means I B cells. Method of production of drugs: Mr injection of 0,25% or 0,5% Tricuspid Regurgitation 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Amines. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia.